Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study-March 2024-www.financetom.com

Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study

Dec 30, 2024 4:36 AM

Dec 30 (Reuters) - Axsome Therapeutics ( AXSM ) said on

Monday its experimental treatment for the Alzheimer's

disease-related agitation met the main goal of a late-stage

trial.

Previous page： Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business Next page： Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business

Oct 21, 2024

Sanofi SA ( SNY ) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi’s consumer health unit. The new step in Opella’s journey paves the way for creating a standalone player in consumer healthcare while supporting Sanofi’s strategy and increased focus on innovative...

Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell

Oct 21, 2024

09:08 AM EDT, 10/21/2024 (MT Newswires) -- Regenxbio ( RGNX ) reported Monday a 97% reduction in anti-VEGF injections at nine months in a Phase II study of ABBV-RGX-314 for wet age-related macular degeneration, or AMD. In the subretinal treatment of the second eye, 78% of patients remained injection-free, the company said. Visual acuity and retinal thickness were maintained, with...

AZEK Names Rakesh Mohan Chief Digital, Technology Officer

Oct 21, 2024

09:05 AM EDT, 10/21/2024 (MT Newswires) -- AZEK ( AZEK ) said Monday that Rakesh Mohan has been named chief digital and technology officer. Mohan was most recently chief information officer and vice president of IT at Lennox International ( LII )-owned (LII) Home Comfort Solutions. ...

Nigeria blocks Shell's asset sale in the Niger Delta

Oct 21, 2024

ABUJA, Oct 21 (Reuters) - Nigeria has blocked the sale of Shell's entire onshore and shallow-water oil and gas assets in the Niger Delta, the country's upstream regulator said on Monday, roughly 10 months after the deal was announced. In a speech at an event in the capital Abuja, Nigerian Upstream Petroleum Regulatory Commission (NUPRC) CEO Gbenga Komolafe said the...